Market Overview
The anatomic pathology market will show rapid growth due to the high incidence of cancer and other target diseases, growing focus on personalized medicine and a substantial number of supporting programs and training modules by government.
There is rapid growth in the geriatric population and the increasing incidence rate of cancer and other chronic diseases. Rising cases of chronic disease and increasing requirements to address the timely diagnosis of medical conditions are driving the market.
Due to the rapid increase in the prevalence of cancer, there is increasing usage of advanced pathology equipment such as staining systems, gross imaging, and digital microscopes that are poised to improve anatomic pathological practices to some extent. Digital imaging solutions also offer specificity and accuracy-related benefits over conventional techniques, which in turn, boosts the service uptake rate in the overall market.
In addition, growing awareness and an increase in the patient pool in developing countries is also driving the growth of the market. Moreover, the increase in healthcare expenditure and the increase in usage of biomarkers during disease diagnosis are also found driving the market.
Scope of the Report
As per the scope of the report, anatomic pathology is a medical specialty that is concerned with the diagnosis of disease based on the microscopic, macroscopic, biochemical, immunologic and molecular examination of organs and tissues. Anatomic pathology involves visualization of human tissue under a microscope for proper diagnosis of the disease or a pathological condition. Microscopic examination of tissue samples with the help of one or more stains is a standard procedure performed in anatomic pathology.
Key Market Trends
Hospitals Segment is Expected to Dominate the Anatomic Pathology Market During the Forecast Period
Hospitals are expected to dominate the market owing to the high hospitalization rate of cancer patients, coupled with a substantial number of frequent readmissions in hospitals. Moreover, the presence of well-developed infrastructure, as well as well-trained staff in hospital-based pathological laboratories, stimulates the progression of the hospital segment. The segment is also expected to benefit from an increasing number of initiatives undertaken by public and private agencies to promote advanced healthcare systems.
On the other side, a large number of clinical trials through various ongoing projects have spurred the progression of the research laboratories segment. Research laboratories are engaged in offering rapid and comprehensive information about the functioning of diseased tissues, with an overall objective of achieving a high degree of patient satisfaction that is expected to grow in the upcoming future.
North America is Found Leading the Anatomic Pathology Market
North America has been accounted for the largest revenue share due to the presence of major players and supportive government initiatives pertaining to training pathological programs. There is also easy accessibility to advanced technologies, government initiatives for screening cancer patients, favorable reimbursement scenario for anatomic pathology diagnostic tests, increasing healthcare expenditure, and the presence of high-quality infrastructure for hospitals and clinical laboratories in the region that are the major factors driving the growth of the market in North America.
Competitive Landscape
Product innovation and ongoing R&D activities to develop advanced technologies have helped in boosting the growth of the market. Various strategies and collaborations are being adopted by these key players to maintain their market share. The key players are found implementing multiple strategies to maintain their significant share in the marketplace during the forecast period. The strategies implemented include collaborative development, business expansion, and product developments.
Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client’s requirements
- 3 months of analyst support